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Background and Study Objectives. Enterovesical fistula (EVF) is a devastating complication of a variety of inflammatory and
neoplastic diseases. Radiological imaging plays a vital role in the diagnosis of EVF and is indispensable to gastroenterologists
and surgeons for choosing the correct therapeutic option. This paper provides an overview of the diagnosis of enterovesical
fistulae. The treatment of fistulae is also briefly discussed. Material and Methods. We performed a literature review by searching
theMedline database for articles published from its inception until September 2013 based on clinical relevance. Electronic searches
were limited to the keywords: “enterovesical fistula,” “colovesical fistula” (CVF), “pelvic fistula”, and “urinary fistula”. Results. EVF is
a rare pathology. Diverticulitis is the commonest aetiology. Over two-thirds of affected patients describe pathognomonic features
of pneumaturia, fecaluria, and recurrent urinary tract infections. Computed tomography is the modality of choice for the diagnosis
of enterovesical fistulae as not only does it detect a fistula, but it also provides information about the surrounding anatomical
structures. Conclusions. In the vast majority of cases, this condition is diagnosed because of unremitting urinary symptoms after
gastroenterologist follow-up procedures for a diverticulitis or bowel inflammatory disease. Computed tomography is the most
sensitive test for enterovesical fistula.
1. Introduction
Enterovesical fistula (EVF) represents an abnormal commu-
nication between the intestine and the bladder. Although
EVF are uncommon, they cause significant morbidity and
may markedly affect patient’s quality of life. Enterovesical
fistulae most frequently occur as a consequence of advanced-
stage disease or due to traumatic or iatrogenic injuries. The
diagnosis of EVF can be challenging and is often delayed for
several months after symptoms begin. Radiological imaging
plays a vital role in establishing the site, course, and complex-
ity of fistulae and in identifying an aetiological factor. This
paper describes the imaging appearances of enterovesical fis-
tulae and the option for their management.
2. Material and Methods
A comprehensive search strategy was applied for Med-
line/PubMed electronic database from its inception until
September 2013.We selected all human research articles pub-
lished in English, not classified as case report, editorial, com-
ment, letter, or news.The search strategy included the follow-
ing terms: “enterovesical fistula,” “colovesical fistula”, “pelvic
fistula” and “urinary fistula”.
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3. Results and Discussion
We found a total of 274 papers about urinary tract fistulae and
a total of 75 articles specifically related to EVF. Among these,
70 were original articles and 5 were reviews.
3.1. Aetiology of Enterovesical Fistulae. It is estimated that
enterovesical fistulae account for 1 in every 3,000 surgical
hospital admissions [1]. EVF most frequently occur in a
setting of inflammatory bowel disease. Diverticulitis is the
commonest aetiology accounting for approximately 65–79%
of cases, which are almost exclusively colovesical [2–5].
The relative risk for developing enterovesical fistula in the
presence of diverticular disease is between 1 and 4% [4, 6].
The underlying mechanism of it is a direct extension of rup-
tured diverticulum or erosion of a peridiverticular abscess,
into the bladder, and a phlegmon and abscess are the risk
factors for subsequent fistula formation [4, 5, 7]. The second
most common cause of EVF is cancer (10–20% of cases),
followed by Crohn’s disease (5–7%) [4, 8, 9]. While only
approximately 2% of patients with Crohn’s disease develop
EVF, ileovesical fistula remains themost common type [8, 10].
Regional enteritis, secondary to the transmural inflammation
characteristic of Crohn’s colitis,may result in adherence to the
bladder with subsequent erosion into the organ and further
fistula formation [8, 9].Themean duration of Crohn’s disease
at the time of onset of EVF-related symptoms is 10 years and
an average patient’s age is 30 [9]. Less-common inflammatory
causes of EVF include Meckel’s diverticulum, genitourinary
coccidioidomycosis, pelvic actinomycosis, and appendicitis
[11–14]. Advanced-stage colon and bladder malignancies
account for up to one-fifth of all cases, with the latter being
extremely rare [4, 15]. Other urogenital malignancies, as well
as lymphoma, cause EVF only occasionally [16, 17].The iatro-
genic aetiology of enterovesical fistulae may occur as a con-
sequence of general surgical procedures (particularly for col-
orectal cancer, diverticulitis, or inflammatory bowel disease),
as well as vascular and urological interventions [18, 19]. Fis-
tulae may also develop as a complication of both chemo- and
radiation therapy. External beam radiation or brachytherapy
to the bowel in the treatment field can precipitate fistula
formation by inducing progressive endarteritis obliterans,
which subsequently may result in necrosis and breakdown of
mucosal surfaces [20]. Radiation-associated fistulae usually
develop years after radiation therapy for gynaecological or
urological malignancies [20, 21]. Enterovesical fistulae, sec-
ondary to cytotoxic therapy, are extremely rare and have been
previously reported in a patient undergoing chemotherapy
for non-Hodgkin’s lymphoma [22]. Other uncommon causes
of EVF include penetrating abdominal or pelvic injuries and
foreign bodies in the bowel and peritoneum [5, 23].
3.2. Types of Enterovesical Fistulae. Classification of entero-
vesical fistulae is based on the bowel segment involved. All
EVF can be divided into the following 4 primary categories:
(i) colovesical, (ii) rectovesical (including rectourethral), (iii)
ileovesical, and (iv) appendicovesical fistulae.While colovesi-
cal fistula is the most common form of vesicointestinal fistula
and ismost frequently located between the sigmoid colon and
the dome of the bladder, rectovesical fistulae are observed in
the postoperative setting (i.e., after prostatectomy) [24]. A key
consideration in determining optimal management of EVF is
not only the termination point of the fistula tract but also the
complexity of the fistula itself. Simple enterovesical fistulae
are usually small and single and occur in nonradiated tissue.
Complex EVF are larger, have multiple tracts, often develop
in a previously irradiated tissue, and are commonly accom-
panied by a pelvic abscess or a colonic obstruction [2, 21].
3.3. ClinicalManifestations andDiagnosis. Symptoms of vesi-
coenteric fistulaemay originate fromboth the urinary and the
gastrointestinal tracts. However, patients with EVF usually
present with lower urinary tract symptoms, which include
pneumaturia (the most common symptom present in 50–
70% of cases), fecaluria (reported in up to 51%), frequency,
urgency, suprapubic pain, recurrent urinary tract infections
(UTIs), and haematuria [5, 8, 21, 25]. Over 75% of affected
patients describe pathognomonic features of pneumaturia,
fecaluria, and recurrent UTIs due to Escherichia coli, col-
iform bacteria, mixed growth, or enterococci [4, 5, 21]. The
hallmark of enterovesical fistulae is Gouverneur’s syndrome
characterised by suprapubic pain, frequency, dysuria and
tenesmus [26]. Physical signs include malodorous urine and
debris in the urine, as well as less commonly reported fever.
Additionally, symptoms of an underlying disease causing the
fistula may be present. In patients with fistulating Crohn’s
disease, abdominal pain, abdominal mass, and abscess are
more common [27].
3.4. Diagnostic Algorithm. The diagnosis of an enterovesical
fistula poses a significant challenge as there is no consensus
on any clear gold standard for EVF workup. A review of the
literature showed that enterovesical fistulae are most com-
monly diagnosed based on clinical evidence. Nevertheless,
diagnostic verification of EVF is necessary not only to estab-
lish the presence of a fistula but also to exclude stricture of the
bowel and presence of abscess and to evaluate the anatom-
ical region of involved intestine to guide the subsequent
surgery [28]. Although cystoscopy, with the highest yield
in identifying a potential lesion, is an essential component
of the entire investigation process, its findings are usually
nonspecific and include erythema, oedema, and congestion.
Endoscopic evaluation of the urinary bladder fails to identify
EVF in 54–65% of cases [4, 25, 28]. Colonoscopy is not
particularly valuable in detecting fistulae. A detection rate for
EVF can be as low as 8.5% and does not usually exceed 55%
[25, 29, 30]. However, as 10%–15% of colovesical fistulae are
secondary to neoplasms, endoscopic examination of the large
bowel should be an integral part of CVF workup. It is helpful
in determining the nature of the bowel pathology responsible
for the fistula formation [4, 5, 25].
The poppy seed test involves oral intake of 50mg of poppy
seeds mixed in beverage or yoghurt. Since seeds remain
largely undigested through the gastrointestinal tract, they
may appear in urine within 48 hours following intake which
is considered a positive confirmatory test for enterovesical
fistula. Kwon et al. compared the accuracy of the poppy seed
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History suggestive of enterovesical 
fistula
USS of the abdomen and pelvis
Poppy seed test
Abdominopelvic CT with contrast 
and/or MRI in case of 
contraindication to radiation or 
contrast or when complex fistulae
present
Cystoscopy with biopsy ±
colonoscopy with biopsy in case of
colovesical fistula
Figure 1: Diagnostic imaging and procedures algorithm for enter-
ovesical fistulae.
test with CT scanning and nuclear cystography in 20 patients
with surgically confirmedfistulae.Thepoppy seed test yielded
a 100% detection rate, whereas CT scanning and nuclear
cystography yielded rates of 70% and 80%, respectively. The
poppy seeds test is inexpensive and easy to perform; however,
it provides little detail regarding the location and type of
fistula present [29].
The proposed algorithm for diagnosis of enterovesical
fistula is presented in Figure 1.
4. Imaging Techniques and Appearances
4.1. Ultrasonographic Examination. Ultrasonography (USS)
may be useful in the diagnosis of colovesical fistulae. In
some instances, the fistula is easily identified, with no addi-
tional manoeuvers needed [31]. Its detection rate in small
series reached 100% [32]. The yield of the transabdominal
ultrasonographic examination for suspected fistula can be
enhanced by the use of abdominal compression, which
reveals an echogenic “beak sign” connecting the peristaltic
bowel lumen and the urinary bladder [33]. The identification
of the ureteric orifices with their associated urinary jets
and the use of lower abdominal compression are essential
components of this technique.
Anorectal, transrectal, and transvaginal ultrasonography
can help to identify a fistulous tract, as well as its relation
to the adjacent anatomical structures (Figures 2(a), 2(b), and
2(c)) [34, 35].
4.2. Computed Tomography Examination. Computed tomog-
raphy (CT) is the modality of choice for the diagnosis of
enterovesical fistulae due to its high sensitivity for the detec-
tion of EVF, but more importantly it provides essential addi-
tional information about the adjacent anatomical structures
[5, 25, 36]. Moreover, the underlying pathology of colovesical
fistulae is, in the majority of cases, an extraluminal disease
process, and CT scanning is an optimal modality to detect
pericolic complications of the diverticular disease [2–5, 7].
The diagnostic accuracy of computed tomography for detect-
ing colovesical fistulae is up to 90–100% [5, 36–38]. CT scan-
ning should be performed following oral administration of
contrast but prior to intravenous administration of contrast,
in order to permit detection of Gastrografin or other diluted
iodinated contrast agents within the bladder. The findings on
CT, which are suggestive of enterovesical fistula include (i) air
in the bladder (in the absence of previous lower urinary tract
instrumentation), (ii) oral contrast medium in the bladder
on nonintravenous contrast enhanced scans, (iii) presence of
colonic diverticula, and (iv) bladder wall thickening adjacent
to a loop of thickened intestine (Figures 3, 4(a), and 4(b))
[4, 5, 37, 39]. The pathognomonic finding of air within the
urinary bladder contributes to the high diagnostic accuracy
of CT in detecting EVF; however, false positives may occur
following recent lower urinary tract instrumentation or due
to active urinary tract infection with a gas-forming organism.
Compared with conventional axial CT imaging, 3-
dimensional CT provides better visualisation of the anatomi-
cal relationship of the bladder and EVF to adjacent structures
[40, 41]. Majority of modern CT scanners can acquire a
raw data volume enabling almost immediate three planar
reconstruction without additional cost.
4.3.Magnetic Resonance Imaging. Although computed tomo-
graphy is the modality of choice in evaluation of colovesical
fistulae, the actual fistulous tract is identified on CT only
occasionally [36, 37]. Magnetic resonance imaging (MRI) has
excellent intrinsic soft tissue resolution together with its mul-
tiplanar imagining capability. Moreover, MRI allows accurate
depiction of fistulous tract without the necessity of direct
opacification required in CT scanning. Its use in colovesical
fistulae is well established and its sensitivity and specificity
reach up to 100% [25, 42–44]. The appearance of a fistula on
MRI depends whether it is filled with fluid, air, or a combina-
tion of both. Therefore, the use of combined sequences is
ideal. T1-weighted images delineate the extension of the
fistula relative to sphincters and adjacent hollow viscera and
show inflammatory changes in fat planes. On T2-weighted
images, the fistula typically produces a high-signal-intensity,
fluid-filled communication, whereas the air-filled fistulous
tract is seen as a low signal intensity, regardless of the pulse
sequence used [43, 44]. In cases of fistulae due to divertic-
ulitis, abscess (containing high-signal fluid on T2-weighted
images) is commonly seen lying between the inferior wall of
the sigmoid colon and the superior bladder wall (which is
thickened and inflamed) [42].
Use of intravenous gadolinium enhancement signifi-
cantly improves the detection of bladder fistulae. Early
postgadolinium T1-weighted images show enhancement of
tract walls and signal void fluid centrally [44]. Both axial and
sagittal planes are useful for the detection of enterovesical
fistulae [42–44]. Use of short tau inversion-recovery (STIR)
images has not been established in the literature yet. Although
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(a) (b)
(c)
Figure 2: Rectovesical fistula: anorectal endosonographic view of a fistulous orifice in the urinary bladder (arrows) (a), transrectal
ultrasonographic view of a fistulous orifice (arrows) located 6mm from the internal outlet of the bladder (crosses) (b), and transrectal
ultrasonographic view of a fistulous tract adjacent to the left lobe of the prostate (arrows) (c).
Figure 3: Colovesical fistula: axial image in the delayed phase of CT
urogram demonstrates bladder and rectal wall thickening (arrows)
with contrast present in both (∗).
MRI allows for a precise delineation of fistulous tracts, its
high cost and the common lack of MRI access within the
emergency room limit its use to more complex elective cases.
4.4. Radiographic Examinations. A plain abdominal X-ray is
not generally helpful, although when taken with the patient
standingmay show an air-fluid level within the bladder. Simi-
larly, intravenous urography fails to demonstrate the fistula,
unless the patient has severe outlet obstruction [45].
Barium enemas (BE) have a limited role in the diag-
nosis of enterovesical fistulae due to a low sensitivity of
approximately 30% [29, 46]. However, it may be useful in
differentiating diverticular disease from colonic cancer as a
cause of EVF. Radiographic examination of centrifuged first
urine sample obtained immediately after a nondiagnostic BE,
called the Bourne test, may significantly enhance the yield
of the barium study [46, 47]. Radiodense particles detected
in the urine sediment confirm the presence of a fistula [40,
41]. A detection rate for colovesical fistulae can even reach
90% [46]. However, currently its role in an enterovesical
fistula workup ismarginal since CT and othermore advanced
studies provide explicit information regarding not only the
presence or absence of a fistula butmore importantly about its
location, complexity, and surrounding anatomical structures.
Enterovesical fistulae may be evaluated with cystography
which may demonstrate contrast outside the bladder; how-
ever, it is less likely to demonstrate a fistula [25]. A detec-
tion rate for enterovesical fistula ranges between 20% and
30% [29]. The herald sign is a crescentic defect on the upper
margin of the bladder and it represents a perivesical abscess.
The pathognomonic finding of colovesical fistula is the “bee-
hive” sign caused by the elevation of the bladder wall at the
vesical end of the fistulous tract [5, 48].
The use of Tc-99m DTPA as a valuable method in
diagnosis of enterovesical fistula has been reported [49, 50].
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(a) (b)
Figure 4: Colovesical fistula: axial image of contrast enhanced CT of the abdomen and pelvis demonstrates air in the bladder (arrow) and
thickened left bladder wall (a); sagittal image shows bladder wall thickening (arrow) adjacent to a loop of thickened sigmoid colon (arrow
head) (b).
It is a simple and readily available tool, which provides ana-
tomic as well as functional information about the urinary
tract.Moreover, itmay demonstrate the presence and location
of a fistula indicated by the passing of the radioactive urine
from the urinary system into the bowel. The severity of EVF
can be determined by assessing the urine flow rate that passes
through the fistula [51].
Because of the superiority of CT scanning, as a tool for
diagnosis and treatment planning, plain cystography, and
radionuclide renography are only occasionally used in the
evaluation of enterovesical fistulae.
Advantages and disadvantages of diagnostic tests and
procedures used for detection of enterovesical fistulae are
presented in Table 1.
5. Management of Enterovesical Fistulae
5.1. Conservative Management. Nonoperative treatment of
enterovesical fistulae may be an option in nontoxic, min-
imally symptomatic patients with nonmalignant EVF ori-
gin, particularly in those with Crohn’s disease. A trial of
medical therapy including bowel rest, total parenteral nutri-
tion, antibiotics, steroids, immunomodulatory drugs, and
urethral catheter drainage may be warranted [52]. In patients
with colovesical fistulae, conservative management has been
reported to be associated with the same disease-specific mor-
tality as with the surgical treatment [28, 53]. However, others
have found significantly more deaths related to poor physical
condition, progression of malignant disease, and the septic
effect of the EVF [30, 54]. Therefore, nonsurgical manage-
ment of colovesical fistulae is generally reserved for patients
unfit for major intervention or with extensive unresectable
neoplastic process. In those cases, medical therapy with
catheter drainage of the bladder alone or supravesical percu-
taneous diversion could be beneficial. However,most patients
will require a diverting stoma in due course of a disease.
5.2. Surgical Repair. Endoscopic, open, and laparoscopic
approaches have all been used in surgical treatment of entero-
vesical fistulae [2, 8, 52, 55–59]. Colonoscopic closure of iatro-
genic perforations <1 cm is a valuable option of a minimally
invasive treatment. In such cases, repair of the perforation
can be achieved using the TriClip device [55]. Endoscopic
treatment of enterovesical fistulae due to colorectal cancer is
commonly associated with bowel stenosis and requires the
use of covered self-expanding metal stents. This technique
allows for the application of stents within the stenotic
bowel segment, even in the presence of a neoplastic, frag-
ile tissue, without further narrowing of its lumen. How-
ever, this method is contraindicated in the management of
enterovesical fistula caused by diverticulitis as stent place-
ment is associated with high risk of the colon perforation
[60].
Operative management of enterovesical fistulae is mainly
dependent on the underlying pathology, site of the bowel
lesion, and patient’s preoperative status. Both open and lap-
aroscopic approaches have been used for the treatment of
enterovesical fistula [2, 8, 57, 58]. The aim of operative man-
agement is to resect and reanastomose the offending bowel
segment and to close the bladder. The treatment may involve
single-stage or multistage procedures [2, 52]. The former
involves resection and primary anastomosis without a pro-
tective colostomy, whereas, during the latter, resection and
primary anastomosis with colostomy and/or Hartmann pro-
cedure are performed (two-stage procedure) with later clo-
sure of the stoma (three-stage approach). Staged procedures
have been advocated in patients with gross faecal contami-
nation and large intervening pelvic abscesses or in those with
advancedmalignancy or radiation changes [2, 8].Historically,
proximal defunctioning procedures as sole interventions
have been recommended in the management of EVF [61].
Although they are associated with low surgical trauma, they
are unlikely to result in a fistula tract closure. Moreover, a
fistula often recurs following reversal of a colostomy and
patients may still remain prone to urinary sepsis [53].
Bowel resection with primary anastomosis is advocated
in the majority of EVF cases [2, 25]. Successful one-stage
resections have been reported in 18% to 92% of EVF cases [54,
62]. Surgical technique involves blunt dissection of the bowel
from the bladder, resection of the intestine, and primary
anastomosis. As an opening of a fistulous tract in the bladder
may not be directly visible, distention of the bladder with
methylene blue solution instilled through a catheter may
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Table 1: Advantages and disadvantages of diagnostic tests and procedures used for the detection of enterovesical fistulae.
Modality Advantages Disadvantages
Cystoscopy Direct visualisation of the bladderAllows for the biopsy of a lesion
Invasive test
Visualises only intraluminal content
Success rate of 35%–46%
Colonoscopy Helps to identify bowel pathology that caused acolovesical fistula
Invasive test
Visualises only intraluminal content





Accuracy of up to 100%
Does not provide information on




Success rate of up to 100%
Does not provide more detailed




Diagnostic accuracy between 30 and 100%
Provides information about the complexity of a
fistula and the surrounding anatomical structures
X-ray exposure
Expensive
Often fails to identify fistulous tract
MRI
No X-ray exposure
Helpful in complex cases




Useful in differentiating diverticular disease from
colonic cancer
Low perforation rates (<1%)
X-ray exposure
Barium peritonitis
Visualises only intraluminal content
Detection rate of approximately 30%
Bourne test InexpensiveDetection rate for colovesical fistulae of up to 90%
Does not provide information on
fistula location and type
Cystogram Easy to performAvailable
X-ray exposure
Low detection rate
Does not provide information on
fistula location
Not helpful in case of a complex fistula
be helpful. The type of bladder repair, whether excision or
oversewing, is not of critical importance since small defects
do not require closure and may be left to heal spontaneously
[63]. Although no strong evidence is available, if technically
possible, interposition of the omental flap between the blad-
der and intestine may be employed. Such maneuver might
improve healing process and reduce the fistula recurrence
rate due to high vascularity and immunological properties of
the omentum [64].
Surgical management of radiation-induced enterovesical
fistulae is challenging and in severe cases impossible as no
clear planes between the anatomical structures can be iden-
tified. Moreover, radiation-induced fistulae are more likely
to recur. Hence, in such patients, a proximal defunctioning
stoma may be an option as it can improve their quality of
life.
The outcome of enterovesical fistulae management is, in
the majority of cases, excellent. Postoperative recurrence of
EVF is uncommon in patients with benign and nonradiation-
induced fistulae. Persistence of a fistula after presumably
definitive treatment may also be related to malignancy,
nutritional issues, unrecognised foreign body, or surgical fac-
tors.
6. Conclusions
Enterovesical fistulae are an uncommon complication of both
benign and malignant processes. The diagnosis of EVF may,
however, be challenging. With a high index of suspicion
for fistula formation in patients presenting with symptoms
suggestive of abnormal communication between the intestine
and the bladder, appropriate radiological investigation can
lead to a significant reduction in morbidity. Recognition of
a fistulous tract, delineation of its course, and characterisa-
tion of its complexity affect the EVF management. In this
respect, cross-sectional imagingwithCTandMRI remains an
ideal modality option in patients with enterovesical fistulae.
Management of EVF is mainly dependent on the underlying
pathology, site of the bowel lesion, and patient’s preoperative
performance status. Surgical one-stage strategy is a preferred
option in most of the cases.
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